Associate Professor of Medicine, University Wash
Hematology
Dr. Georgiana K. Ellis, MD
|
|
Give Review
Dr. Georgiana K. Ellis works in the field of Hematology. She went to medical school at University of Washington School of Medicine. She over the years received 2 awards: "America's Top Doctors" and "America's Top Doctors for Cancer". Georgiana Ellis is a published physician. She has 38 papers published. The most current publication "Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast cancer." She accepts Medicare.
Publications
- Fluoroestradiol Positron Emission Tomography Reveals Differences in Pharmacodynamics of Aromatase Inhibitors, Tamoxifen, and Fulvestrant in Patients with Metastatic Br...
- PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake.
- Phase III comparison of standard doxorubicin and cyclophosphamide versus weekly doxorubicin and daily oral cyclophosphamide plus granulocyte colony-stimulating factor ...
- The science and practice of bone health in oncology: managing bone loss and metastasis in patients with solid Tumors.
- Randomized trial of denosumab in patients receiving adjuvant aromatase inhibitors for nonmetastatic breast Cancer.
- Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced br...
- Quantitative fluoroestradiol positron emission tomography imaging predicts response to endocrine treatment in breast Cancer.
- Residual tumor uptake of [99mTc]-sestamibi after neoadjuvant chemotherapy for locally advanced Breast carcinoma predicts survival.
- Evaluation of the internal mammary lymph nodes by FDG-PET in locally advanced breast Cancer (LABC).
- HER-2 testing in breast Cancer using parallel tissue-based methods.
- Changes in blood flow and metabolism in locally advanced breast Cancer treated with neoadjuvant chemotherapy.
- Amphiphysin paraneoplastic syndrome: a delayed diagnosis of Breast carcinoma.
- Myalgias and arthralgias associated with paclitaxel.
- Dose-dense anthracycline-based chemotherapy for node-positive breast Cancer.
- Blood flow and metabolism in locally advanced breast Cancer: relationship to response to therapy.
- Antiemesis clinical practice guidelines in oncology.
- Antiemesis.
- New applications of monoclonal antibodies to the diagnosis and prognosis of breast Cancer.
- Bone marrow involvement in epithelial ovarian Cancer by immunocytochemical assessment.
- Alternating weekly doxorubicin and 5-fluorouracil/leucovorin followed by weekly doxorubicin and daily cyclophosphamide in stage IV breast Cancer. A Southwest Oncology ...
- Effect of delay in radiation in the combined modality treatment of breast Cancer.
- Cisplatin and novobiocin in the treatment of non-small cell lung Cancer. A Southwest Oncology Group study.
- Impact of FDG PET on defining the extent of disease and on the treatment of patients with recurrent or metastatic breast Cancer.
- Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast Cancer. A Southwest Oncology Group Study.
- Value of combined FDG PET and MR imaging in the evaluation of suspected recurrent local-regional breast Cancer: preliminary experience.
- Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast Cancer.
- 18fluorodeoxyglucose positron emission tomography to detect mediastinal or internal mammary metastases in breast Cancer.
- Monitoring the response of patients with locally advanced Breast carcinoma to neoadjuvant chemotherapy using [technetium 99m]-sestamibi scintimammography.
- Infusional paclitaxel and weekly vinorelbine chemotherapy with concurrent filgrastim for metastatic breast Cancer: high complete response rate in a phase I-II study of...
- Dose-intensive vinorelbine with concurrent granulocyte colony-stimulating factor support in paclitaxel-refractory metastatic breast Cancer.
- Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast Cancer: ...
- Serial 2-[18F] fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) to monitor treatment of bone-dominant metastatic breast Cancer predicts time to progress...
- [Tc-99m]-sestamibi uptake and washout in locally advanced breast Cancer are correlated with tumor blood flow.
- Effect of denosumab on bone mineral density in women receiving adjuvant aromatase inhibitors for non-metastatic breast Cancer: subgroup analyses of a phase 3 study.
- False positive tumor markers: elevation in patients with breast Cancer on FAC-type chemotherapy and correlation with the development of hand-foot syndrome.
- 'Neo-FAC' (5-fluorouracil, doxorubicin, and cyclophosphamide) for poor-prognosis stage IV breast Cancer: a Southwest Oncology Group Phase II Study.
- Potential of chemotherapy-herb interactions in adult Cancer patients.
Schools
University of Washington
University Wash Affil
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Awards
- America's Top Doctors
- America's Top Doctors for Cancer
Education
-
University of Washington -
University of Washington School of Medicine
Hospital
-
Seattle Children's Hospital -
University of Washington Medical Center
Drug Facts
| NPI NUMBER | 1821174681 | |
| NPPES Provider LastName | ELLIS | |
| NPPES Provider FirstName | GEORGIANA | |
| NPPES Provider ZIPCode | 98109 | |
| NPPES Provider State | WA | |
| Specialty Description | Medical Oncology | |
| Total Claim Count | 488.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821174681 |
| Last Name Of The Provider | ELLIS |
| First Name Of The Provider | GEORGIANA |
| View All |
Similar Doctors
|
|
Dr. Ben M. Chue, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. J S. Tolman, MD |
|
|
Dr. Michael L. Linenberger, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Jane C. Huang, MD |
|
|
Dr. Allison J. Shaw, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Keith R. Loeb, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Zandra K. Klippel, MD |
|
|
Dr. Filippo Milano, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claudia C. Astigarraga, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William E. Hobbs II, MD |
|
|
Dr. Martina M. Crysandt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tessa C. Kerre, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melinda A. Biernacki, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Schmitt, MD |
|
|
Dr. Benjamin J. Uttenthal, MD |
|
|
Cameron J. Turtle, MB BS |